Funding Fever: How Venture Capital Type Shapes Post-IPO Outcomes in Biotechnology
This study aims to investigate how corporate venture capital (CVC) and independent venture capital (IVC) influence innovation and financial outcomes in biotechnology firms following their initial public offering (IPO), and how factors like technological fit and failure tolerance mediate innovation outcomes. Using a sample of US-based biotechnology firms that completed IPOs between 2010 and 2020, w